ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 94 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2013. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $3,896,000 | +69.5% | 645,973 | +1.2% | 0.00% | 0.0% |
| Q3 2019 | $2,299,000 | +31.8% | 638,575 | -1.8% | 0.00% | – |
| Q2 2019 | $1,744,000 | -7.3% | 650,592 | +2.3% | 0.00% | -100.0% |
| Q1 2019 | $1,882,000 | +90.5% | 635,835 | +2.3% | 0.00% | – |
| Q4 2018 | $988,000 | -57.4% | 621,545 | -1.5% | 0.00% | -100.0% |
| Q3 2018 | $2,321,000 | +31.9% | 630,861 | +1.5% | 0.00% | – |
| Q2 2018 | $1,759,000 | -24.3% | 621,676 | -0.8% | 0.00% | -100.0% |
| Q1 2018 | $2,325,000 | +37.3% | 626,669 | +6.6% | 0.00% | – |
| Q4 2017 | $1,693,000 | -37.7% | 587,819 | -2.9% | 0.00% | -100.0% |
| Q3 2017 | $2,718,000 | -3.2% | 605,293 | -1.0% | 0.00% | 0.0% |
| Q2 2017 | $2,808,000 | +21.5% | 611,634 | +11.4% | 0.00% | 0.0% |
| Q1 2017 | $2,311,000 | +2.0% | 549,119 | +0.1% | 0.00% | 0.0% |
| Q4 2016 | $2,266,000 | -45.4% | 548,534 | +7.0% | 0.00% | 0.0% |
| Q3 2016 | $4,152,000 | -1.7% | 512,591 | -5.3% | 0.00% | 0.0% |
| Q2 2016 | $4,224,000 | +1.1% | 541,551 | +0.0% | 0.00% | 0.0% |
| Q1 2016 | $4,179,000 | -31.0% | 541,292 | -3.6% | 0.00% | -50.0% |
| Q4 2015 | $6,057,000 | +60.8% | 561,430 | +3.0% | 0.00% | +100.0% |
| Q3 2015 | $3,766,000 | -34.2% | 545,037 | -15.6% | 0.00% | -50.0% |
| Q2 2015 | $5,722,000 | -7.1% | 645,862 | +3.3% | 0.00% | 0.0% |
| Q1 2015 | $6,162,000 | -22.1% | 624,936 | -3.2% | 0.00% | 0.0% |
| Q4 2014 | $7,911,000 | +24.4% | 645,912 | +1.3% | 0.00% | 0.0% |
| Q3 2014 | $6,359,000 | -8.9% | 637,323 | -30.9% | 0.00% | +100.0% |
| Q2 2014 | $6,984,000 | +362.5% | 922,646 | +101.1% | 0.00% | – |
| Q1 2014 | $1,510,000 | -1.0% | 458,886 | -0.2% | 0.00% | – |
| Q4 2013 | $1,526,000 | -46.6% | 459,650 | -51.4% | 0.00% | – |
| Q3 2013 | $2,858,000 | -18.4% | 946,250 | +120.9% | 0.00% | -100.0% |
| Q2 2013 | $3,503,000 | – | 428,328 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,700,000 | $82,075,000 | 8.82% |
| RTW INVESTMENTS, LP | 1,622,633 | $19,877,000 | 7.35% |
| ProQuest Associates IV LLC | 1,122,957 | $13,757,000 | 6.97% |
| RA Capital Management | 2,500,000 | $30,625,000 | 3.29% |
| DOHENY ASSET MANAGEMENT /CA | 517,450 | $6,339,000 | 3.03% |
| DAFNA Capital Management LLC | 197,500 | $2,419,000 | 1.91% |
| Rhenman & Partners Asset Management AB | 368,000 | $4,508,000 | 1.31% |
| SECTORAL ASSET MANAGEMENT INC | 2,373,810 | $29,079,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,920,300 | $35,774,000 | 1.28% |
| Bain Capital Public Equity Management, LLC | 2,928,750 | $35,877,000 | 0.90% |